Sure, here is the content you requested:
—
[1]: Projections of prevalence, lifetime risk, and life expectancy of … teaching and research institutions in France or abroad, or from public or private research centers. L’archive ouverte pluridisciplinaire HAL, est … of prevalence, lifetime risk, and life expectancy of parkinson’s disease (2010-2030) in France. Movement Disorders, 2018, 33 (9), pp.1449-1455. 10.1002/mds.27447 … URL: https://hal.science/hal-03193026/document
[2]: Parkinson’s disease – Fondation de France There are 25,000 annual new cases of Parkinson’s disease in France.By 2030, the number of patients could increase by 56%, which would mean one person in 120 over 45 would have the disease*. … Fondation de France reaffirms it’s support for medical research on Parkinson’s disease and continues to contribute to the progress of new treatments.URL: https://www.fondationdefrance.org/en/parkinson-disease
[3]: Parkinson’s disease incidence and prevalence assessment in France using …Background and purpose: The incidence and prevalence of Parkinson’s disease are important for public health planning yet there is a lack of representative, up-to-date estimations for France. Methods: For this cross-sectional study, subjects with suspected Parkinson’s were identified in the EGB database, a 1/97 random sample of the national healthcare insurance database, linked to … new perspectives for Parkinsonian patients. In addition,patients who have benefited from deep electrostimulation operations find a meaningful improvement in their quality of life.
Exchange and support
The disease should not prevent from living fully and many people continue to flourish despite the difficulties and practice suitable physical activities. Speech groups for patients and caregivers regularly come together to exchange and support each other. The program for these meetings is available on the French Parkinson 39 website. An data meeting is scheduled for March 14 at 8 p.m.,in the Séquanise de Poligny.
The next meetings
a conference entitled “Parkinson and food disease” is scheduled for Saturday, april 12 at the common house of the Marjorie, with interventions by Bilitis Faucheux, dietician, Valérie Bujandas, naturopath, and Doctor Éric Berthier, neurologist in Lons- Le-Auanier.In addition, an action will be carried out with the paramedical professions to raise awareness of the existence of the committee in the Jura.
Contacts Dominique Léfier,Departmental Delegate Committee Jura.Such. 07 83 60 15 11 Mail: [email protected] Website: https://www.franceparkinson.fr/comite-39/
—
Interview on Parkinson’s Disease in France
Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide. In France, the prevalence and incidence of the disease are notable concerns. Recently, we had the prospect to interview an expert on Parkinson’s disease to gain insights into the current situation and future projections.
Q: Could you provide an overview of the current prevalence and incidence of Parkinson’s disease in France?
A: According to recent studies, ther are approximately 25,000 new cases of Parkinson’s disease in France each year. By 2030, the number of patients is expected to increase by 56%, meaning one person in 120 over the age of 45 will have the disease.
Q: What are the projections for the lifetime risk and life expectancy of individuals with Parkinson’s disease?
A: Projections indicate that the lifetime risk and life expectancy of individuals with Parkinson’s disease have been studied extensively. Research published in Movement Disorders suggests that by 2030, the prevalence, lifetime risk, and life expectancy of Parkinson’s disease will see significant changes. These projections are crucial for healthcare planning and resource allocation.
Q: How does the Fondation de France contribute to the fight against Parkinson’s disease?
A: The Fondation de France reaffirms its support for medical research on Parkinson’s disease and continues to contribute to the progress of new treatments. Their efforts are vital in advancing our understanding of the disease and developing more effective therapies.
Q: what are the upcoming initiatives and meetings related to Parkinson’s disease in France?
A: A conference entitled “Parkinson and food disease” is scheduled for Saturday, April 12 at the common house of the Marjorie. The event features interventions by Bilitis Faucheux, a dietician, Valérie Bujandas, a naturopath, and Doctor Éric berthier, a neurologist in Lons-le-Saunier. Additionally, an action will be carried out with the paramedical professions to raise awareness of the existence of the commitee in the Jura.
Conclusion
The interview provides valuable insights into the current and future landscape of Parkinson’s disease in France.With increasing prevalence and incidence, the need for robust medical research and public awareness initiatives is more critical than ever. The Fondation de France’s continued support and upcoming events highlight the collaborative efforts to combat this neurological disorder.
Related
